Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Morristown Medical Center
mi
from
Morristown, NJ
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Morristown Medical Center
mi
from
Morristown, NJ
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Albany Medical Center Hospital
mi
from
Albany, NY
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Albany Medical Center Hospital
mi
from
Albany, NY
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Westchester Medical Center
mi
from
Hawthorne, NY
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Westchester Medical Center
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Mount Carmel East
mi
from
Columbus, OH
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Mount Carmel East
mi
from
Columbus, OH
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Bend Memorial Clinic
mi
from
Bend, OR
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Bend Memorial Clinic
mi
from
Bend, OR
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
St. Luke's University Hospital
mi
from
Bethlehem, PA
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
St. Luke's University Hospital
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Physican's Regional Medical Center
mi
from
Knoxville, TN
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Physican's Regional Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Houston VA
mi
from
Houston, TX
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Houston VA
mi
from
Houston, TX
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
University Of Utah Hospital
mi
from
Salt Lake City, UT
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
University Of Utah Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Providence Regional Medical Center Everett
mi
from
Everett, WA
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Providence Regional Medical Center Everett
mi
from
Everett, WA
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Charleston Area Medical Center
mi
from
Charleston, WV
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Charleston Area Medical Center
mi
from
Charleston, WV
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Froedert Hospital
mi
from
Milwaukee, WI
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Froedert Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Mount Sinai Hosp
mi
from
New York, NY
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated:  9/8/2015
Hamilton General Hospital
mi
from
Hamilton,
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Status: Enrolling
Updated: 9/8/2015
Hamilton General Hospital
mi
from
Hamilton,
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigator Site
mi
from
Birmingham, AL
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigator Site
mi
from
Birmingham, AL
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigator Site
mi
from
Birmingham, AL
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigator Site
mi
from
Birmingham, AL
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Huntsville, AL
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Mobile, AL
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Mobile, AL
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Mobile, AL
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Mobile, AL
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Muscle Shoals, AL
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Anchorage, AK
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Anchorage, AK
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Gilbert, AZ
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Phoenix, AZ
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Phoenix, AZ
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Phoenix, AZ
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Little Rock, AR
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Little Rock, AR
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Little Rock, AR
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Little Rock, AR
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Anaheim, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Bellflower, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Bellflower, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Berkley, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Berkley, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Loma Linda, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Loma Linda, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Loma Linda, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Loma Linda, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative site
mi
from
Los Angeles, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative site
mi
from
Los Angeles, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Mather, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Mather, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Oceanside, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Palm Springs, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Palm Springs, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Pomona, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Pomona, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Sacramento, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
Sacramento, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
San Diego, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
San Diego, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated:  9/9/2015
Novartis Investigative Site
mi
from
San Diego, CA
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Status: Enrolling
Updated: 9/9/2015
Novartis Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials